Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST
Related Experiment Videos
Antonio Coca1, Franz H Messerli, Athanase Benetos
1Hospital Clinic (IDIBAPS), University of Barcelona, Barcelona, Spain.
Insights
Stroke risk in hypertensive coronary artery disease patients is influenced by various factors. Achieving blood pressure below 140/90 mm Hg significantly reduces stroke risk, while factors like black race and prior heart attack increase it.
Area of Science:
- Cardiology
- Neurology
- Hypertension Management
Background:
- Understanding stroke risk factors in coronary artery disease (CAD) patients is crucial.
- Hypertension is a common comorbidity in CAD patients, increasing stroke risk.
Purpose of the Study:
- To identify predictors of stroke in hypertensive, stable CAD patients.
- To analyze the impact of baseline characteristics and blood pressure control on stroke risk.
Main Methods:
- Analysis of 22,576 patients from the INternational VErapamil SR-trandolapril STudy (INVEST).
- Utilized Cox proportional-hazards models to identify stroke predictors.
- Examined baseline characteristics and on-treatment blood pressure (BP).
Main Results:
- Stroke occurred in 377 patients (6.1/1000 patient-years), with 28% fatal.
- Increased stroke risk associated with older age, black race, US residency, prior myocardial infarction, smoking, stroke/TIA, arrhythmia, diabetes, and bypass surgery.
- Achieving BP <140/90 mm Hg significantly reduced stroke risk.
Conclusions:
- Stroke is a significant, often fatal, complication in hypertensive CAD patients.
- Black race, US residency, severe vascular disease, and arrhythmia predict higher stroke risk.
- Effective blood pressure control (<140/90 mm Hg) is key to reducing stroke risk.
Background And Purpose:
Our understanding of factors influencing stroke risk among patients with coronary artery disease is incomplete. Accordingly, factors predicting stroke risk in hypertensive, clinically stable coronary artery disease patients were determined with data from the INternational VErapamil SR-trandolapril STudy (INVEST).
Methods:
The effect of baseline characteristics and on-treatment blood pressure (BP) were analyzed to determine the risk of stroke (fatal or nonfatal) among the 22 576 patients enrolled. Cox proportional-hazards models (unadjusted, adjusted, and time dependent) were used to identify predictors of stroke among subgroups with these characteristics present at entry and on-treatment BP.
Results:
Excellent BP control (at 24 months, >70% <140/90 mm Hg) was achieved during 61 835 patient-years of follow-up, as 377 patients had a stroke (6.1 strokes/1000 patient-years) and 28% of those patients had a fatal stroke. Increased age, black race, US residency, and history of prior myocardial infarction, smoking, stroke/transient ischemic attack, arrhythmia, diabetes, and coronary bypass surgery were associated with an increased risk of stroke. Achieving a systolic BP <140 mm Hg and a diastolic BP <90 mm Hg was associated with a decreased risk of stroke. There was no statistically significant difference in stroke risk comparing the verapamil SR-based with the atenolol-based treatment strategy (adjusted hazard ratio=0.87; 95% CI, 0.71 to 1.06; P=0.17).
Conclusions:
Among hypertensive patients with chronic coronary artery disease, stroke was an important complication associated with significant mortality. Black race, US residency, and conditions associated with increased vascular disease severity and arrhythmia predicted increased stroke risk, whereas achieving a BP <140/90 mm Hg on treatment predicted a reduced stroke risk.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...